---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-153622"
form_type: "8-K"
ticker: "PTPI"
cik: "0001815903"
company_name: "Petros Pharmaceuticals, Inc."
filed_at: "2021-12-27T23:59:59+00:00"
generated_at: "2026-06-27T22:23:00.340809+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Petros Pharmaceuticals raises $7.5M in registered direct offering and private placement

## Summary
- Sold 2,186,589 shares at $3.43 each to accredited investors, including largest shareholder.
- Issued warrants to purchase up to 1,639,942 shares at $3.50, exercisable for five years.
- Net proceeds expected ~$6.9M after fees; used for men's health platform expansion and working capital.
- Katalyst Securities served as financial advisor; receives $560K fee and 110,000 warrants.
- Closing occurred December 27, 2021.

## SEC filing metadata
- accession: 0001104659-21-153622
- form_type: 8-K
- ticker: PTPI
- cik: 0001815903
- company_name: Petros Pharmaceuticals, Inc.
- filed_at: 2021-12-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815903/000110465921153622/0001104659-21-153622-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815903/000110465921153622/tm2136334d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-153622
- JSON: https://secwatch.observer/filing/0001104659-21-153622.json
- Plain text: https://secwatch.observer/filing/0001104659-21-153622.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.